ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-PO984

Proximal tubular cell isolation during human acute kidney injury

Session Information

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • De Seigneux, Sophie M., Geneva University Hospital, Geneva, Switzerland
  • Legouis, David, Geneva University Hospital, Geneva, Switzerland
  • Galichon, Pierre, Sorbonne Universite, Paris, France
Background

There is an urgent need to discover and validate the pathophysiological pathways involved in human acute kidney injury (AKI). Proximal tubular cells (PTCs) are the cells primarily injured during AKI and their maladaptive repair contribute to AKI to chronic kidney disease (CKD) transition. It is very important to develop non-invasive tools that will help to improve our understanding of the signaling pathways contributing to the maladaptive repair.

Methods

We collected urine from patients hospitalized in the ICU of University Hospital of Geneva, presenting or not AKI. We here propose a novel method to isolate specifically PTCs from human urine using a combination of Magnetic-Activated Cell Sorting (MACS) sorting and Fluorescent-Activated Cell Sorting (FACS) . We have characterized the sorted cells, and show how these cells can be used to determine pathophysiological pathways in human AKI.

Results

Isolated PTCs are viable, can be cultured for at least three passages (a) and retain the expression of several proximal tubule specific markers at the level protein (b) and of mRNA (c). We report that our technique is more sensitive than routine microscopic approach used to identify the presence of tubular cells in the urine during clinical AKI (d). There is a clear correlation between isolated PTC cell numbers and the severity of AKI as defined by KDIGO staging guidelines (e). RNA sequencing and pathway analysis confirmed alterations in PTCs cell cycle in AKI patients, which correlated to the severity of AKI (f).

Conclusion

We show that isolation of PT cells from urine is possible during human AKI episode. These cells can be used to study the pathways involved in AKI and we could confirm alterations of the cell cycle in PTCs collected from AKI patients. Thus, we believe that PTCs isolated from human urine will allow the identification and characterization of novel pathways in AKI and the AKI to CKD transition.

Funding

  • Private Foundation Support